Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 20 Neoplasm Metastasis 12 Prostatic Neoplasms 11 Neoplasms 8 Carcinoma, Hepatocellular 8 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Pheochromocytoma 2 Paraganglioma 2 Neuroendocrine Tumors 2 Multiple Myeloma 2 Melanoma 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Medullary 2 Carcinoid Tumor 2 Brain Neoplasms 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urethral Neoplasms 1

Interventions

niraparib 1 cabozantinib 1 avelumab 1 Sunitinib 1 Paclitaxel 1 Gemcitabine 1 Everolimus 1 Cisplatin 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urothelial Cancer × cabozantinib × Clear all

NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1/2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡